Trial Profile
A Phase II Study Of Epothilone B Analog BMS-247550 (NSC 710428) In Patients With Relapsed Aggressive Non-Hodgkin's Lymphomas.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Aug 2012
Price :
$35
*
At a glance
- Drugs Ixabepilone (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Adverse reactions; Therapeutic Use
- 01 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Sep 2010 Actual end date (Aug 2010) added as reported by ClinicalTrials.gov.